MDM2 and cancer: Collectively, as depicted in Fig. 6D, our results suggest a model in which, in unstressed conditions, TSPYL2 is maintained at low levels by MDM2-dependent degradation, but after DNA damage, in normal and female cancer cells, it is stabilized through E2F1-dependent gene transcription and protein deubiquitination.